|

ATRA Clinical Trials

2 actively recruiting trials across 1 location

Pipeline

Phase 2: 1

Top Sponsors

  • Rita Assi1
  • First Affiliated Hospital of Zhejiang University1

Indications

  • Cancer2
  • Refractory Non-Hodgkin Lymphoma1
  • Relapsed Non-Hodgkin Lymphoma1
  • Refractory Hodgkin Lymphoma1
  • Relapsed Hodgkin Lymphoma1

Other1 trial

A Study on the Efficacy and Safety of Oral All-trans Retinoic Acid Combined With Toripalimab in TNBC.
N/A

Indianapolis, Indiana1 trial

A Phase II Study of the Combination of Pembrolizumab and ATRA Combination Treatment of Relapsed HL and B-NHL

Indiana University Health Melvin and Bren Simon Comprehensive Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.